v3.26.1
Stockholders' Equity and Stock-based Compensation (Tables)
9 Months Ended
Mar. 31, 2026
Stockholders' Equity and Stock-based Compensation [Abstract]  
Schedule of Compensation Expense Allocated For the three and nine months ended March 31, 2026, the Company recorded stock-based compensation expense allocated as follows (in thousands):
 
    
For the

Three Months Ended
March 31, 2026
    
For the

Nine Months Ended
March 31, 2026
 
Selling, general and administrative and research and development expenses
   $ 186      $ 186  
  
 
 
    
 
 
 
Total
   $ 186      $ 186  
  
 
 
    
 
 
 
Summary of Restricted Stock Units ("RSUs") Activity
A summary of the restricted stock units (“RSUs”) activity during the nine months ended March 31, 2026 is presented below:
 
    
Number of
RSUs
    
Weighted Average Grant Date
Price
 
RSUs June 30, 2025
     —         —   
Granted
     326,312      $ 4.89  
Vested
     —         —   
Forfeited
     —         —   
  
 
 
    
 
 
 
RSUs undelivered March 31, 2026
     326,312      $ 4.89  
  
 
 
    
 
 
 
Summary of the Warrant Activity
A summary of the warrant activity during the nine months ended March 31, 2026 is presented below:
 
    
Number of Warrants
 
Outstanding as of June 30, 2025
     —   
Issued
     30,203,376  
Exercised
     (382,095
  
 
 
 
Outstanding as of March 31, 2026
     29,821,281  
Schedule of Warrants Outstanding
The following table presents information related to warrants as of March 31, 2026:
 
Exercise Price
  
Outstanding Number

of Warrants
    
Weighted Average

Remaining Life in Years
 
$9.38
     9,131,600        4.7  
$12.50
     9,131,600        4.7  
$18.75
     9,131,600        4.7  
$6.25
     2,400,001        4.3  
Various (> $47.00)
     26,480        Various  
  
 
 
    
  
 
29,821,281